Multi-institutional study of nuclear KIFC1 as a biomarker of poor prognosis in African American women with triple-negative breast cancer

Nuclear KIFC1 (nKIFC1) predicts worse outcomes in breast cancer, but its prognostic value within racially distinct triple-negative breast cancer (TNBC) patients is unknown. Thus, nKIFC1 expression was assessed by immunohistochemistry in 163 African American (AA) and 144 White TNBC tissue microarrays...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogden, Angela, Garlapati, Chakravarthy, Li, Xiaoxian (Bill), Turaga, Ravi Chakra, Oprea-Ilies, Gabriela, Wright, Nikita, Bhattarai, Shristi, Mittal, Karuna, Wetherilt, Ceyda Sönmez, Krishnamurti, Uma, Reid, Michelle D., Jones, Mildred, Gupta, Meenakshi, Osan, Remus, Pattni, Sonal, Riaz, Ansa, Klimov, Sergey, Rao, Arundhati, Cantuaria, Guilherme, Rida, Padmashree C. G., Aneja, Ritu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5316996/
https://www.ncbi.nlm.nih.gov/pubmed/28218233
http://dx.doi.org/10.1038/srep42289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5316996/
https://www.ncbi.nlm.nih.gov/pubmed/28218233
http://dx.doi.org/10.1038/srep42289

Ejemplares similares